- Bentley’s founders and management will retain control and will hold majority of the capital
- Keensight is a European growth buyout firm
- AP Moller is a privately held investment company
Keensight Capital, AP Moller Holding and Bonit Capital have invested in Bentley Endovascular Group, a medical technology holding company.
Stockholm, Sweden-based Bentley controls its key subsidiary Bentley InnoMed and Qmedics.
Bentley’s founders and management will retain control and will hold majority of the capital and the votes in the company.
Keensight, AP Moller and Bonit Capital will support Bentley by helping it expand its geographical footprint, strengthen its products and prepare the company for its upcoming IPO process, according to a release.
The firm will leverage its “network and capacities to support Bentley in their international expansion, especially when entering the US,” said James Mitchell, partner at Keensight.
Annika Sunnanväder, daughter of co-founder and major shareholder Lars Sunnanväder, is appointed chairperson of the board of directors.
Keensight is a European growth buyout firm that invests in companies with revenues in the range of €10 million to €400 million. It is based in Paris.
AP Moller is a privately held investment company based in Copenhagen.
Bentley InnoMed manufactures implants and catheters for the endovascular treatment of peripheral vascular and aortic disease. It generated sales revenue of around €69 million in 2022.
Qmedics provides dilatation balloons and acts as a key supplier of essential components for Bentley InnoMed.
Bonit is a family-owned investment company based in Stockholm, Sweden.
No financial details of the transaction were disclosed.